TELA Bio
TELA
40 hedge funds and large institutions have $35.1M invested in TELA Bio in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
0.13% more ownership
Funds ownership: 59.35% → 59.48% (+0.13%)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
13% less funds holding
Funds holding: 46 → 40 (-6)
23% less capital invested
Capital invested by funds: $45.5M → $35.1M (-$10.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
Top Sellers
TELA Hedge Fund Activity: Q3 2025 in Review
40 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q3 2025, worth a combined $35.1M — down 23% from $45.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TELA and 1 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 10 added.
The largest buyer was WealthTrust Axiom, adding an estimated $372K. The largest seller was Vanguard Group, cutting an estimated $197K.
- 40 institutional investors held TELA Bio (TELA) as of Q3 2025, down from 46 in Q2 2025.
- Funds reported $35.1M of TELA Bio stock for Q3 2025, down 23% quarter-over-quarter.
- 1 fund opened new TELA Bio positions in Q3 2025 and 7 closed out, a net change of -6 holders.
- The largest TELA Bio buyer in Q3 2025 was WealthTrust Axiom, an estimated $372K added.
- The largest TELA Bio seller in Q3 2025 was Vanguard Group, an estimated $197K sold.
Based on aggregated 13F filings for Q3 2025.